Cancer cells get their energy by secreting their own insulin, and they stimulate themselves to grow by secreting their own insulin-like growth factor (IGF). These are their mechanisms of malignancy. Insulin and IGF work by attaching to special cell membrane receptors, and these receptors are sixteen times more concentrated on cancer cell membranes than on normal cells. These receptors are the key to IPT. Using insulin in IPT, the low dose chemotherapy gets channeled specifically inside the cancer cells, killing them more effectively, and with minimal chemotherapy side effects.
Insulin Potentiation Therapy was developed in Mexico by a family of physicians – the Drs. Donato Perez Garcia. Over the last twenty-five years they and other doctors have collaborated with their Mexican colleagues to provide a sound scientific basis for the therapy, and getting documentation of this published in the scientific medical literature. Their common goal has always been, and yet remains, to get IPT properly studied in this country so greater numbers of physicians and patients in the United States could use it. An in vitro study at Georgetown University showed insulin increases the penetration of chemotherapy into cancer cells 10,000 fold. Another study from Uruguay on chemotherapy resistant patients (treatment failures) showed shrinkage of tumors when the patients were then treated with IPT.IPT is a powerful drug delivery system that uses ordinary chemotherapy drugs in greatly reduced doses, and makes these work without most of the common side-effects associated with conventional chemotherapy treatment.